IP Library Patent Application 11172058
Patent Application
App. No. 11/172,058

Iontophoresis device

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/172,058
Abstract

An iontophoresis device is capable of suppressing the change in a composition of a drug solution and/or an electrolyte solution of a working electrode structure, thereby allowing the working electrode structure to be retained in a stable state for a long period of time. The iontophoresis device includes: an electrolyte solution holding part for holding an electrolyte solution in which an electrolyte to be dissociated, in a solution, to first electrolytic ions of a first polarity and second electrolytic ions of a second polarity is dissolved; and a drug solution holding part for holding a drug solution in which a drug to be dissociated, in a solution, to the drug ions of the first polarity and drug counter ions of the second polarity is dissolved. A first ion-exchange membrane for selectively passing the ions of the second polarity and a porous separation membrane for blocking passage of molecules and ions each having a molecular weight exceeding a threshold are placed between the electrolyte solution holding part and the drug solution holding part.

Claims (26)

1 . An iontophoresis device for administering drug ions to a living body, comprising:

an electrolyte solution holding part for holding an electrolyte solution in which an electrolyte to be dissociated, in a solution, to first electrolytic ions of a first polarity and second electrolytic ions of a second polarity opposite to the first polarity is dissolved; and

a drug solution holding part for holding a drug solution in which a drug to be dissociated, in a solution, to the drug ions of the first polarity and drug counter ions of the second polarity is dissolved, the drug solution holding part being placed on a front side of the electrolyte solution holding part,

wherein a first ion-exchange membrane for selectively passing the ions of the second polarity and a semi-permeable separation membrane for blocking passage of molecules and ions each having a molecular weight greater than a threshold molecular weight are placed between the electrolyte solution holding part and the drug solution holding part.

2 . The iontophoresis device according to claim 1 wherein the porous separation membrane blocks passage of the second electrolytic ions.

3 . The iontophoresis device according to claim 1 wherein the porous separation membrane blocks passage of one of the electrolyte molecules and the first electrolytic ions.

4 . The iontophoresis device according to claim 1 wherein the porous separation membrane blocks passage of one of the drug molecules and the drug ions.

5 . The iontophoresis device according to claim 1 wherein the electrolyte solution holding part is sealed in the porous separation membrane formed in a bag shape.

6 . The iontophoresis device according to claim 1 wherein the drug solution holding part is sealed in the porous separation membrane formed in a bag shape.

7 . An iontophoresis device for administering drug ions to a living body, comprising:

an electrolyte solution holding part for holding an electrolyte solution in which an electrolyte to be dissociated, in a solution, to first electrolytic ions of a first polarity and second electrolytic ions of a second polarity opposite to the first polarity is dissolved;

a drug solution holding part for holding a drug solution in which a drug to be dissociated, in a solution, to the drug ions of the first polarity and drug counter ions of the second polarity is dissolved, the drug solution holding part being placed on a front side of the electrolyte solution holding part; and

a first ion-exchange membrane for selectively passing ions of the second polarity, the first ion-exchange membrane being placed between the electrolyte solution holding part and the drug solution holding part, wherein the first ion-exchange membrane blocks passage of the second electrolytic ions.

8 . The iontophoresis device according to claim 7 , further comprising a second ion-exchange membrane for selectively passing the ions of the first polarity, the second ion-exchange membrane being placed on a front side of the drug solution holding part.

9 . An iontophoresis device for administering drug ions to a living body, comprising:

an electrolyte solution holding part for holding an electrolyte solution in which an electrolyte to be dissociated, in a solution, to first electrolytic ions of a first polarity and second electrolytic ions of a second polarity opposite to the first polarity is dissolved;

a drug solution holding part for holding a drug solution in which a drug to be dissociated, in a solution, to the drug ions of the first polarity and drug counter ions of the second polarity is dissolved, the drug solution holding part being placed on a front side of the electrolyte solution holding part; and

a first ion-exchange membrane for selectively passing ions of the second polarity, the first ion-exchange membrane being placed between the electrolyte solution holding part and the drug solution holding part,

wherein the first ion-exchange membrane blocks passage of one of the electrolyte molecules and the first electrolytic ions.

10 . The iontophoresis device according to claim 9 , further comprising a second ion-exchange membrane for selectively passing the ions of the first polarity, the second ion-exchange membrane being placed on a front side of the drug solution holding part.

11 . An iontophoresis device for administering drug ions to a living body, comprising:

an electrolyte solution holding part for holding an electrolyte solution in which an electrolyte to be dissociated, in a solution, to first electrolytic ions of a first polarity and second electrolytic ions of a second polarity opposite to the first polarity is dissolved;

a drug solution holding part for holding a drug solution in which a drug to be dissociated, in a solution, to the drug ions of the first polarity and drug counter ions of the second polarity is dissolved, the drug solution holding part being placed on a front side of the electrolyte solution holding part; and

a first ion-exchange membrane for selectively passing ions of the second polarity, the first ion-exchange membrane being placed between the electrolyte solution holding part and the drug solution holding part,

wherein the first ion-exchange membrane blocks passage of one of the drug molecules and the drug ions.

12 . The iontophoresis device according to claim 11 , further comprising a second ion-exchange membrane for selectively passing the ions of the first polarity, the second ion-exchange membrane being placed on a front side of the drug solution holding part.

Assignments (5)
RESCISSION OF PRIOR ASSIGNMENT Recorded Mar 10, 2008
From: TRANSCU LTD.
To: TTI ELLEBEAU, INC.
Reel/Frame 020626/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2007
From: TTI ELLEBEAU, INC.
To: TRANSCU LTD.
Reel/Frame 020236/0175 →
CHANGE OF NAME Recorded Dec 7, 2007
From: ELLEBEAU, INC.
To: TTI ELLEBEAU, INC.
Reel/Frame 020214/0336 →
MERGER Recorded Dec 5, 2007
From: TRANSCUTANEOUS TECHNOLOGIES, INC.
To: ELLEBEAU, INC.
Reel/Frame 020200/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2005
From: MATSUMURA, AKIHIKO; MATSUMURA, TAKEHIKO; NAKAYAMA, MIZUO; AKIYAMA, HIDEROU
To: TRANSCUTANEOUS TECHNOLOGIES INC.
Reel/Frame 016749/0898 →